Boston Scientific announces resolution of corporate warning letter

Boston Scientific Corporation (NYSE: BSX) today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited in the Company's corporate warning letter have been resolved.  

"The resolution of the corporate warning letter marks a major milestone in our journey of continuous quality improvement," said Ray Elliott, President and Chief Executive Officer of Boston Scientific.  "Quality is our highest priority and our greatest responsibility.  While our quality work will never be done, we have revolutionized our approach and transformed our culture, and we are confident that our commitment to the highest levels of quality will create a competitive advantage for Boston Scientific."  

SOURCE Boston Scientific Corporation